You are here

Policy

 

Ethicists from the University of Basel have developed a biosecurity framework specific to neurotechnology while calling for a ban on dual-use technology with the aim of regulating mental privacy and integrity of humans. Findings were published in Neuron.

As cyberattack become increasingly common incidents, healthcare professionals must push security to the forefront. In a presentation given at the annual meeting of the Radiological Society of North America (RSNA) in Chicago, Jim Whitfill, CMO of innovation Health Partners and president of Lumetis, described the current cybersecurity environment and detailed how professionals can take steps toward improving privacy.

Despite increased prevention efforts and longer lifespans, heart failure rates are at a high in the United Kingdom and are continuing to climb, according to new research published in The Lancet.

The U.S. Food and Drug Administration (FDA) has approved a remote feature allowing programming sessions given through telehealth platforms to patients who have had at least six months of experience with their cochlear implant sound processor.

The U.S. Food and Drug Administration (FDA) has approved the first digital pill with an ingestion tracking system to tell physicians whether patients have taken their medication.

 

Recent Headlines

21st Century Cures Act won’t get Senate vote before long recess

It’s been more than a year since the House passed the 21st Century Cures Act, which aims to speed up regulatory approval for medical devices and drugs, but the Senate’s chief advocate for the legislation said it’ll be at least another seven weeks before its put up for a vote.

HHS issues new guidance on ransomware attacks

HHS’ Office of Civil Rights (OCR) has released its much-anticipated guidance on how healthcare organizations can better understand and respond to ransomware attacks, including defining such incidents as breaches that require affected individuals to be notified under HIPAA in most circumstances.

FDA-approved stomach-draining device may face lawsuit

The Food and Drug Administration has approved several new weight loss interventions in the past year, but one in particular seems to be raising eyebrows among physicians.

Nearly 600 U.S. clinics could be selling unregulated stem cell treatments

The risks of “stem cell tourism” might be overplayed, according to a new paper published June 30 in the journal Cell Stem Cell. But only because the real risks of unregulated stem cells might actually be within the U.S.

 
Biden rallies participants to double cancer progress in 'moonshot' kick-off

Vice President Joe Biden led a major step toward completing his “moonshot” task of curing cancer June 29, when he spoke at the first Cancer Moonshot Summit.

 
FDA approves test for quicker detection of hospital ‘superbugs’

The Food and Drug Administration (FDA) has given a thumbs up to a test hospitals can use to identify certain types of antibiotic-resistant infections more quickly.

Study reveals differing standards for approval of American, European medical devices

Medical devices play a vital role in patient care, but how they are approved and regulated are vastly different in the United States compared to the European Union.

Health IT groups want more time to prepare for MACRA

Electronic health record (EHR) vendors and the clinicians they serve need more than a few months to adapt to the Medicare Access and CHIP Reauthorization Act, according to numerous comments submitted to CMS by health IT groups.

CDC failed to disclose lab mishaps to Congress

The Centers for Disease Control and Prevention (CDC) told Congress it left out 34 incident reports involving lab mistakes from information it provided to a congressional investigation in 2014, according to USA Today.

IT group wants interoperability standards for drug monitoring

As the House and Senate work in a conference committee on anti-opioid abuse legislation, a coalition called Health IT Now has asked lawmakers to lay out more specific standards on how different states’ prescription drug monitoring programs (PDMPs) will be interoperable.

 

Pages